Share-Based Compensation	9 Months Ended
Share-Based Compensation	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation The Company recognized total share-based compensation expense in selling, general and administrative expenses in the consolidated statement of operations of $818 and $443 for the three months ended September 30, 2022 and 2021, respectively, and $1,589 and $1,814 for the nine months ended September 30, 2022 and 2021, respectively. Should there be a Change in Control of the Company, unvested shares would immediately vest. The Company's related share-based compensation is comprised of the following: Restricted Stock Units During the nine months ended September 30, 2022 and 2021, the Company granted certain employees and executive officers equity awards in the form of restricted stock units ("RSU") that are subject to a combination of time and performance-based conditions under the 2017 Equity Compensation Plan (the "2017 Plan"), totaling 486 and 414 RSUs, respectively. During the three months ended September 30, 2022, 23 RSUs were granted. No RSUs were granted during the three months ended September 30, 2021. Each RSU entitles the grantee to one unit of the Company's common stock. The time-based RSUs vest annually over a three-year period on the anniversary date of each grant. Unvested time-based RSUs will be forfeited if the grantee separates from the Company prior to its vesting date. During the nine months ended September 30, 2022 and 2021, the related compensation expense was recorded based on a weighted average price per share of $1.90 and $2.36, respectively. During the three months ended September 30, 2022, the related compensation expense was recorded based on a price per share of $1.74 The number of common shares to be issued under the performance-based RSUs will be determined based on three levels of performance metrics based on the Company's earnings and will be assessed on an annual basis for the years ended December 31, 2022, 2023 and 2024 for the RSUs granted during the nine months ended September 30, 2022 and for the years ended December 31, 2021, 2022 and 2023 for the RSUs granted during the nine months ended September 30, 2021. If the Company meets the performance metrics for any one of the measurement periods, such units will vest on the next anniversary date of the grant date. All vested RSUs will be settled on the third anniversary of the grant date. Unvested RSUs are subject to forfeiture if the grantee separates from the Company prior to its vesting date. During the nine months ended September 30, 2022 and 2021, the Company determined it was not probable that the target performance metric would be met for each of the RSU grants and, therefore, did not record any share-based compensation expense related to such RSUs. Deferred Stock Units During the nine months ended September 30, 2022 and 2021, the Company granted certain employees, executive officers and independent members of the Board of Directors equity awards in the form of deferred stock units ("DSU") that are subject to a combination of time and performance-based conditions and, in the case of independent members of the Board of Directors, immediate vesting, under the 2017 Plan, totaling 1,066 and 780 DSUs, respectively. DSUs totaling 276 and 5 were granted during the three months ended September 30, 2022 and 2021, respectively. Each DSU entitles the grantee to one unit of the Company's common stock. The time-based DSUs vest annually over a three-year period on the anniversary date of each grant. Unvested time-based DSUs will be forfeited if the grantee separates from the Company prior to its vesting date. During the nine months ended September 30, 2022 and 2021, the related compensation expense was recorded based on a weighted average price per share of $1.86 and $2.36 respectively. During the three months ended September 30, 2022 and 2021, the related compensation expense was recorded based on a weighted average price per share of $1.74 and $2.57, respectively. The number of common shares to be issued under the performance-based DSUs will be determined based on three levels of performance metrics based on the Company's earnings and will be assessed on an annual basis for the years ended December 31, 2022, 2023 and 2024 for the DSUs granted during the nine months ended September 30, 2022 and for the years ended December 31, 2021, 2022 and 2023 for the DSUs granted during the nine months ended September 30, 2021. If the Company meets the performance metrics for any one of the measurement periods, such units will vest on the next anniversary date of the grant date. Unvested RSUs are subject to forfeiture if the grantee separates from the Company prior to its vesting date. During the nine months ended September 30, 2022 and 2021, the Company determined it was not probable that the target performance metric would be met for each of the RSU grants and, therefore, did not record any share-based compensation expense related to such RSUs. Vested DSUs will be issued immediately upon separation from the Company. Stock Options At September 30, 2022 and 2021, the Company had approximately 1,123 and 1,353 stock options outstanding, respectively, with a weighted average exercise price of $3.83 and $3.87, respectively. No stock options were granted during the nine months ended September 30, 2022 and 2021. During the nine months ended September 30, 2022 and 2021, options lapsed for approximately 230 and 211 shares, respectively, with a weighted average exercise price of $4.05 and $4.95, respectively.